Artificial intelligence can now generate thousands of potential drug molecules in the time it once took to design one, ...
GlobalData on MSN
Co-Diagnostics files FDA 510(k) for flu and RSV PCR test
The molecular diagnostics company's concurrent CLIA Waiver by Application, if granted, would allow testing in decentralised point-of-care settings.
GenScript Biotech and Tamarind Bio collaborate to connect artificial intelligence molecular design with laboratory validation: New Jersey Friday, August 7, 2026, 16:00 Hrs [IST] G ...
LabPMM ®, an Invivoscribe ® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is ...
The six-month pilot is designed to evaluate the potential scalability of bringing physician-ordered, blood-based OkaiDx laboratory-developed ...
An electronic measurement tool will allow for high-velocity, high-volume measurements to complement molecular data.
The Nevada Health & Bioscience Corp. project will house advanced laboratory services, a blood donation center and new medical ...
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro ® instrument in ...
1d
First metabolically activated molecular glue degrader may target cancer cells under oxidative stress
Investigators at Dana-Farber Cancer Institute have developed a platform for systematically discovering molecular glues that ...
Scientists at the Universities of Liverpool and Oxford have developed a promising new way to kill antibiotic-resistant ...
The dashboard expansion comes as public health officials report rising cyclosporiasis activity. As of July 28, 2026, ...
Cleveland Clinic scales lab operations to handle up to 400 daily cyclospora tests amid the largest U.S. outbreak on record.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results